Anti-HIV drugs have improved the survival prospects of people with HIV or AIDS to the point that death rates among the recently diagnosed in industrialized countries have become comparable to those never exposed to the virus, according to a newly published European study.
Medical records show that before 1996, when combinations of antiviral drugs became available, the death rates for HIV-infected patients were 41 times higher than the death rate of people of comparable age not exposed to the virus in 10 European nations and Australia.
Death rates fell dramatically by 1997, to 31 times the norm, and continued dropping until they reached six times the norm by 2006.
Among a subgroup of HIV-positive people, those diagnosed and treated with the latest anti-HIV drug cocktails since 1999, the analysis found virtually no difference in death rates between them and uninfected people of similar age.
By 2006, deaths attributed to AIDS had fallen 94% compared with pre-1996 levels, said the study authors, led by Kholoud Porter of the Medical Research Council Clinical Trials Unit in London.
Their work, which analyzed the records of more than 16,000 patients, was published Tuesday in The Journal of the American Medical Association.
The study did warn that there was an increased risk of death for HIV-infected people of all ages based on the amount of time they have been living with the virus. (The Advocate)
These comments are reproduced as written by visitors to this Web site. They have not been edited for content, grammar, or spelling. The viewpoints appearing here are those of the writer, and do not necessarily reflect the opinion or views of advocate.com, The Advocate, or its affiliates.
Be the first to comment on this story.
If you would like to submit a comment for posting, please fill out the form above.
All comments submitted via this form are subject to posting or publication. (To send a private letter to an Advocate editor or writer, please use the e-mail button at the top of the page, or use snail mail.) If you would like your comment considered for publication in The Advocate magazine, please include your full name, your city of residence, and a phone number where you can be reached during business hours so that we can confirm your identity. Your e-mail address and telephone number are strictly confidential and will not be shared or used for any purpose other than to contact you about your comment.
See the Contact page for sending comments for reasons other than responding to Advocate editorial and news stories.
Please note that comments sent by fax or snail mail are unlikely to be posted, although they will be considered for publication along with all letters received via e-mail or via this Web page. Comments that chiefly concern Advocate.com content will be considered for posting only on the Web site. The Advocate reserves the right to edit submitted comments for grammar, spelling, obscenities, or libel; we will, however, do our best to preserve the original comment's style and intent. Comments considered for publication in The Advocate magazine may also be edited for length.